Remy Peptides FAQ: Storage, Delivery & COA

Retatrutide is a triple-agonist research peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. Developed by Eli Lilly as LY-3437943, it is currently in Phase 3 clinical trials. It represents the most advanced multi-receptor metabolic compound in its class. For current regulatory progress, see our retatrutide approval status guide.

Every batch is independently verified at ≥99.2% purity via HPLC analysis by Janoshik Analytical, a leading third-party testing laboratory. A Certificate of Analysis (COA) is included with every order; our Peptide COA Guide explains how to read HPLC purity, assay, endotoxin, TFA, and heavy-metals fields.

The Retatrutide Pen is a prefilled Pen containing 30mg of stabilized, pH-balanced solution. No reconstitution is required. Each click delivers 0.1mg, with 300 total clicks per pen. See the Retatrutide Pen Guide for the full click map and format details.

Each box contains:

• 1× Prefilled Pen (30mg Retatrutide)
• 20× Pen Needles (5mm 31G)
• 1× Research Instruction Leaflet
• Certificate of Analysis

When stored at 2–8°C, the stabilized solution maintains potency for up to 12 months from the date of manufacture. Always check the expiry date on your COA.

Each click of the pen mechanism delivers 0.1mg of Retatrutide (10 clicks per mg). The pen contains 300 total clicks (30mg) with a full dial range of 60 clicks (6mg). This eliminates reconstitution variables and ensures repeatable output across research protocols. For exact dose math, use the Retatrutide Dosage Calculator or review the dosage guide.

Each box includes 20 pen needles (31G × 5mm) compatible with the Pen format.

Store between 2–8°C (standard refrigerator temperature). Do not freeze. Protect from light. All deliveries are cold-chain controlled to maintain stability. Our Peptide Stability & Storage Guide covers broader handling notes for research peptides and prefilled formats.

Single pen: AED 1,800. 3-pen bundle: AED 1,650/pen (save AED 450). 5-pen bundle: AED 1,500/pen (save AED 1,500). Bulk orders of 100+ pens receive custom pricing via WhatsApp.

We accept Card (secure payment link sent via WhatsApp), Cash on Delivery, and USDT cryptocurrency on the TRC-20 network. Card payment links are sent after order confirmation. USDT payments require no bank intermediary — send directly to our wallet with no conversion fees. Orders are verified on-chain within 30 minutes. TRC-20 only — sending on ERC-20 or BEP-20 will result in permanent loss of funds.

No. You can order a single pen. Volume discounts begin at 3 pens. Bulk pricing is available for orders of 100+ pens.

Yes. Orders of 100+ pens receive negotiated per-unit pricing, priority cold-chain fulfilment, and a dedicated account manager. Contact us via WhatsApp for a same-day quote.

Yes. Contact us via WhatsApp with your institution details and we will provide a formal invoice suitable for institutional procurement.

Due to the nature of research chemicals and cold-chain requirements, we cannot accept returns once delivered. If you receive a damaged or incorrect product, contact us within 24 hours for a replacement.

Orders placed before 4 PM receive same-day delivery across Dubai. Other emirates receive next-day delivery for orders placed before 12 PM. All deliveries are temperature-controlled via cold-chain logistics.

Yes. Dubai orders arrive same day (order by 4 PM). Abu Dhabi, Sharjah, Ajman, Ras Al Khaimah, Fujairah, and Umm Al Quwain receive next-day delivery (order by 12 PM).

Free delivery on all UAE orders, regardless of quantity.

Currently, we stock and deliver within the UAE only. For international research inquiries, contact us via WhatsApp to discuss availability.

All pens are shipped in insulated cold-chain packaging with temperature monitoring to ensure the product arrives between 2–8°C.

Research peptides may be legally purchased and used for in-vitro laboratory research purposes in the UAE. Per UAE MoHAP Circular 17/2022, peptides may not be marketed for therapeutic use without registration. All Remy Peptides products are sold strictly for laboratory research.

No. Retatrutide is currently an investigational compound in Phase 3 clinical trials conducted by Eli Lilly. It is not approved for human or veterinary use in any jurisdiction. Remy Peptides supplies it exclusively for in-vitro laboratory research.

Purchases are restricted to qualified research professionals aged 21 and over. By ordering, you confirm that the product will be used exclusively for in-vitro laboratory research and not for human or veterinary diagnosis or treatment.

This circular from the UAE Ministry of Health and Prevention establishes that peptide compounds may not be marketed for therapeutic use without formal registration. Remy Peptides complies by selling exclusively for research purposes.

Yes. Every order includes a Certificate of Analysis from Janoshik Analytical, batch documentation, and research-use labeling to support institutional compliance requirements.

Retatrutide is a triple-agonist (GLP-1 + GIP + GCGR) while Semaglutide targets only GLP-1. The additional glucagon receptor activation in Retatrutide increases energy expenditure, a mechanism absent from single-agonist therapies. Preclinical data shows ~20–24% body weight change vs ~15% for Semaglutide. See our detailed comparison.

• GLP-1 (Glucagon-Like Peptide-1): appetite suppression, insulin secretion.
• GIP (Glucose-Dependent Insulinotropic Polypeptide): additive insulin enhancement.
• GCGR (Glucagon Receptor): energy expenditure and thermogenesis.

Remy Peptides sources and supplies research-grade Retatrutide independently verified by Janoshik Analytical. The investigational pharmaceutical compound is developed by Eli Lilly for clinical trials.

Every batch undergoes independent HPLC purity analysis by Janoshik Analytical, a leading laboratory specializing in pharmaceutical-grade compound verification. Results consistently show ≥99.2% purity. Full COA reports are provided with every order.